Hier finden Sie grundlegende Angaben zu klinischen Studien des Comprehensice Cancer Centers Mainfranken (CCC MF)
Filter aktiv
Seite 29 - Studien 281 bis 290 von insgesamt 338
- Rekrutierung läuftA Randomized Phase II Trial Evaluating Fruquintinib in Combination with Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer without Active Liver Metastases
- Rekrutierung läuftR-Pola-Glo – A prospective multicenter phase 2 study of the chemotherapy-light combination of intravenous rituximab with the antibody-drug conjugate polatuzumab vedotin and the bispecific antibody glofitamab in previously untreated aggressive B-cell lymphoma patients above 60 years of age ineligible for a fully dosed R-CHOPMolekulare Marker
- Rekrutierung läuftA PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTICD20 X ANTI-CD3 BISPECIFIC ANTIBODY, VERSUS INVESTIGATOR’S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1)
- Rekrutierung läuft
An Open-Label Study to Assess the Anti-Tumor Activity and Safety of REGN1979, an Anti CD20 x Anti-CD3 Bispecific Antibody, in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphom
- Rekrutierung läuftRadical antegrade modular pancreatosplenectomy versus conventionaldistal pancreatosplenectomy for pancreatic cancer – The multicenter,randomized controlled RAMPS-Trial
- Rekrutierung läuftRB-registry: a clinical registry for prospective data on retinoblastoma epidemiology and clinical course
- Rekrutierung läuftA Retrospective, Multicountry Study of Clinical Outcomes in Patients with Relapsed/ Refractory Multiple Myeloma Treated with T-cell Redirectors Outside of Clinical Trials (REALiTEC)
- Rekrutierung läuftEffekt einer zusätzlichen Braun-Fußpunkt-Anastomose bei Patienten nach PankreaskopfresektionDFG - Projektnummer 416055422
- Rekrutierung läuftA Phase I Trial to Determine the Maximum Tolerated Dose and Patient-specific Dosimetry of Fractionated Intracavitary Radioimmunotherapy With Lu-177 Labeled 6A10 Fab-fragments in Patients With Glioblastoma After Standard Treatment
- Rekrutierung läuftRegisterplattform Hämatologische Neoplasien (RUBIN) - Erweiterung des Tumorregisters Lymphatische Neoplasien